Sources: Foxconn's iPhone output in India has dropped by more than 50% because of COVID-19 infections among workers
Production of the Apple iPhone 12 (AAPL.O) at a Foxconn (2317.TW) factory in India has slumped by more than 50% because workers infected with COVID-19 have had to leave their posts, two sources told Reuters.
Context & Ripple Effects
Foxconn's prospective India production was initially framed as a way to reduce Apple's dependence on China. Earlier in 2020, iPhone factories had already cut staffing and overtime amid weaker demand; this report instead identifies a supply-side loss of available labor.
The distinction matters because an India assembly base only diversifies Apple’s footprint if its production capacity remains operable when demand requires it.
First-order effects
- Workers leaving after COVID-19 infections reduce Foxconn’s India output of Apple’s iPhone 12 by more than half, cutting the phones available from that factory.
- Foxconn loses staffed manufacturing capacity in India, while Apple has less immediately usable iPhone assembly output from the site.
Second-order effects
- Unlike the earlier demand-led reductions in iPhone factory staffing, this disruption makes worker health an operational capacity constraint for Apple and Foxconn’s production planning.
- Apple’s India diversification effort faces a more immediate resilience test: production location alone does not ensure that a factory’s labor capacity is available.
Third-order effects
- If similar workforce disruptions recur, Apple and Foxconn will need to value qualified, operable capacity across sites rather than treat geographic expansion as sufficient supply-chain redundancy.
- The episode points toward manufacturing networks being assessed on their ability to sustain output through local disruptions, not just on nominal factory footprint.
The trend: Apple’s assembly diversification is becoming a resilience challenge as much as a geographic one, with usable factory capacity dependent on local operating conditions.